Our Company

Stix Enterprises LLC is a botanical processing company dedicated to producing ultra high purity, hemp-derived cannabinoid ingredients through scientifically rigorous, documented, quality-controlled methodologies.

Our work is grounded in analytical precision, controlled processing environments, and a commitment to advancing the scientific understanding of hemp’s naturally occurring bioactive compounds.

Headquartered at 1120 Larkin Drive in Wheeling, Illinois — in a building we own — our operational infrastructure incorporates advanced purification and isolation technologies, including multi-stage winterization, high-efficiency solvent recovery, precision fractional distillation, and high-purity crystallization systems.

While our full extraction platform is still under development, we are engineering a controlled, scalable extraction workflow designed to integrate seamlessly with our downstream purification operations. This phased development approach ensures that each unit operation is validated for reproducibility, contaminant control, and alignment with evolving regulatory and quality standards.

We source compliant U.S.-grown hemp biomass and apply a vertically integrated quality framework that includes raw material qualification, in-process analytical verification, and comprehensive final product testing. This ensures that every ingredient meets defined specifications for cannabinoid composition, residual solvents, heavy metals, pesticides, and microbial safety.

Stix Enterprises LLC is a botanical processing company dedicated to producing ultra-high-purity, hemp-derived cannabinoid ingredients through scientifically rigorous, documented, quality-controlled methodologies. Our work is grounded in analytical precision, controlled processing environments, and a commitment to advancing the scientific understanding of hemp's naturally occurring bioactive compounds.

Founded in 2019 and headquartered in Wheeling, Illinois, STIX has built a vertically integrated operation spanning Midwest craft-sourced hemp biomass, laboratory-grade analytical infrastructure, and proprietary track-and-trace technology. Our long-term vision is to unlock the full potential of hemp-derived compounds to improve the quality of life for end-users worldwide.

Stix Enterprises is built on the expertise and passion of three founders who bring complementary skills to every aspect of the business — from extraction science and technology to operations and business development.

Brian graduated from Northern Illinois University before beginning his career in the labor staffing industry. Within only a few years of gaining operational and managerial experience, he founded his own staffing firm in the early 2000s. The company continues to operate successfully today as a privately held enterprise, reflecting his long-standing commitment to sustainable business development and disciplined leadership.

Building on that success, Brian established Stix Enterprises LLC, where he serves as Owner and Chief Executive Officer. What began as a personal interest gradually evolved into a focused professional mission: since 2019, Brian has dedicated himself to advancing the scientific understanding and practical applications of the hemp plant, with a particular emphasis on identifying its naturally occurring therapeutic benefits.

Under his leadership, Stix has made significant investments in advanced analytical and testing technologies to remain at the forefront of cannabinoid research, quality assurance, and product development. Brian’s overarching goal is to leverage the full potential of hemp-derived compounds to improve the well-being and quality of life of patients and end users.

Sam graduated from the University of Wisconsin–Parkside with a degree in Chemistry, bringing a strong foundation in molecular design, synthesis, and advanced analytical methodology. He joined Stix Enterprises immediately after completing his studies in 2020 and has since become an indispensable force behind the company’s scientific and operational development. Before earning his degree, Sam had already secured a patent related to novel chemical processes and compound development.

As Chief Scientific Officer, Sam oversees the design, implementation, and continuous refinement of all scientific and technical operations. He has led the development of Stix’s core processing methodologies, including the conceptualization and optimization of extraction, distillation, and isolation workflows — central to the company’s high standards for purity, reproducibility, and process control.

Beyond his technical expertise, Sam brings a genuine passion for understanding how the hemp plant can improve human health and well-being, translating those findings into safe, effective, and scientifically validated cannabinoid ingredients.

Garrett graduated from the University of Illinois with a degree in Economics and Informatics, equipping him with a strong analytical foundation and a deep understanding of data systems, operational modeling, and technology-driven process optimization. He began his career as a Project Manager in the supply chain sector, where he played a central role in developing the white glove delivery service infrastructure for Williams Sonoma and Pottery Barn.

He joined Stix Enterprises in late 2023 and quickly became a key contributor to the company’s analytical and technological advancement. Drawing on his background in informatics and systems architecture, Garrett collaborated with software engineers to design and build a fully customized track and trace platform tailored specifically to Stix’s production environment.

This proprietary system enables comprehensive digital modeling of operational workflows, predictive analysis of process outcomes, and real-time visibility into material movement and performance metrics — significantly enhancing the organization’s ability to forecast yields, identify inefficiencies, and maintain rigorous data integrity.

We are advancing into the planning and procurement phase for the equipment required to establish a fully operational, in-house hemp extraction facility. This build-out represents a significant step toward full vertical integration, strengthening our control over biomass preparation, primary extraction methodology, post-processing workflows, and distillation and isolation parameters.

By controlling these variables internally, we can improve batch-to-batch consistency, tailor extraction parameters to specific product requirements, enhance quality assurance through direct oversight of critical control points, and increase operational efficiency — positioning us to produce higher quality hemp derivatives with greater precision, reliability, and scalability.

We have also acquired an high-purity dual-stage crystallization system engineered by DEC/AWL. Its dual-stage configuration enables controlled supersaturation, nucleation, and crystal growth under tightly regulated thermal and solvent composition gradients — supporting high-purity cannabinoid isolation with improved reproducibility, reduced impurity entrapment, and enhanced scalability compared to conventional single-stage platforms.

Our Commitment

Our long-term vision is to leverage the full therapeutic potential of hemp-derived compounds to improve the quality of life for patients and end users.

By combining rigorous science, transparent operations, and reliable supply, Stix Enterprises supports partners developing formulations intended to advance wellness, symptom management, and overall end-user outcomes.

STIX Enterprises operates from our facility at 1120 Larkin Drive, Wheeling, IL 60090. Our Midwest location puts us within driving distance of our craft hemp biomass suppliers and within one hour of POPE Scientific — the manufacturer of our wiped-film evaporation systems — ensuring rapid support and seamless equipment service.

All hemp biomass is grown within the region under a contract-farming model with 70+ Midwest farm partners, emphasizing soil health, cannabinoid expression, and plant-level care over large-scale commodity farming.